S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Snowflake’s bullish tailwind is turning into a gale-force wind
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
2 energy drink makers to wake up your portfolio
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Snowflake’s bullish tailwind is turning into a gale-force wind
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
2 energy drink makers to wake up your portfolio
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Snowflake’s bullish tailwind is turning into a gale-force wind
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
2 energy drink makers to wake up your portfolio
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Snowflake’s bullish tailwind is turning into a gale-force wind
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
2 energy drink makers to wake up your portfolio
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts

Soleno Therapeutics Stock Price, News & Analysis (NASDAQ:SLNO)

$28.94
-0.89 (-2.98%)
(As of 12/4/2023 ET)
Compare
Today's Range
$28.28
$30.53
50-Day Range
$20.67
$29.83
52-Week Range
$0.85
$30.53
Volume
389,262 shs
Average Volume
394,074 shs
Market Capitalization
$882.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.00

Soleno Therapeutics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
31.3% Upside
$38.00 Price Target
Short Interest
Healthy
3.33% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
-0.13mentions of Soleno Therapeutics in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$15.12 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.43) to ($1.29) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

122nd out of 952 stocks

Electromedical Equipment Industry

2nd out of 21 stocks


SLNO stock logo

About Soleno Therapeutics Stock (NASDAQ:SLNO)

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

SLNO Stock Price History

SLNO Stock News Headlines

All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Soleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High at $30.42
3 Biotech Stocks With Big-Time Breakthrough Potential
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
4 Analysts Have This to Say About Soleno Therapeutics
Soleno Therapeutics Inc SLNO
Why Shares of Soleno Therapeutics Dropped on Wednesday
See More Headlines
Receive SLNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Soleno Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/19/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SLNO
Employees
25
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$38.00
High Stock Price Target
$40.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+31.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-24,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.27 per share

Miscellaneous

Free Float
21,715,000
Market Cap
$882.67 million
Optionable
Not Optionable
Beta
-1.39
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














SLNO Stock Analysis - Frequently Asked Questions

Should I buy or sell Soleno Therapeutics stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Soleno Therapeutics in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SLNO shares.
View SLNO analyst ratings
or view top-rated stocks.

What is Soleno Therapeutics' stock price target for 2024?

3 equities research analysts have issued 12-month target prices for Soleno Therapeutics' shares. Their SLNO share price targets range from $35.00 to $40.00. On average, they anticipate the company's share price to reach $38.00 in the next year. This suggests a possible upside of 31.3% from the stock's current price.
View analysts price targets for SLNO
or view top-rated stocks among Wall Street analysts.

How have SLNO shares performed in 2023?

Soleno Therapeutics' stock was trading at $1.98 at the start of the year. Since then, SLNO stock has increased by 1,361.6% and is now trading at $28.94.
View the best growth stocks for 2023 here
.

When is Soleno Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our SLNO earnings forecast
.

How were Soleno Therapeutics' earnings last quarter?

Soleno Therapeutics, Inc. (NASDAQ:SLNO) released its earnings results on Tuesday, November, 7th. The company reported ($0.95) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by $0.33.

When did Soleno Therapeutics' stock split?

Soleno Therapeutics shares reverse split before market open on Friday, August 26th 2022. The 1-15 reverse split was announced on Friday, August 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Soleno Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soleno Therapeutics investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), SCYNEXIS (SCYX), OPKO Health (OPK), ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Miragen Therapeutics (MGEN), Vaxart (VXRT), Dynavax Technologies (DVAX) and TherapeuticsMD (TXMD).

Who are Soleno Therapeutics' major shareholders?

Soleno Therapeutics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vivo Capital LLC (32.06%), Carlyle Group Inc. (22.96%), Adage Capital Partners GP L.L.C. (13.28%), RA Capital Management L.P. (12.40%), Silverarc Capital Management LLC (3.70%) and Emerald Advisers LLC (2.49%). Insiders that own company stock include Bhatnagar Anish, Jack W Schuler, James H Mackaness, Kristen Yen and Perceptive Advisors Llc.
View institutional ownership trends
.

How do I buy shares of Soleno Therapeutics?

Shares of SLNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SLNO) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -